newdrugapprovals.org
GS 9883, Bictegravir an HIV-1 integrase inhibitor
GS 9883, bictegravir CAS 1611493-60-7 PHASE 3 HIV-1 integrase inhibitor (2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2&…